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SNAT2The sodium coupled neutral amino acid transporter 2 (SNAT2/SAT2/ATA2) is expressed in the mammary gland
(MG) and plays an important role in the uptake of alanine and glutamine which are the most abundant amino
acids transported into this tissue during lactation. Thus, the aim of this study was to assess the amount and local-
ization of SNAT2before delivery and during lactation in ratMG, and to evaluatewhether prolactin and the dietary
protein/carbohydrate ratio might inﬂuence SNAT2 expression in the MG, liver and adipose tissue during lacta-
tion. Our results showed that SNAT2 protein abundance in the MG increased during lactation and this increase
was maintained along this period, while 24 h after weaning it tended to decrease. To study the effect of prolactin
on SNAT2 expression, we incubated MG explants or T47D cells transfected with the SNAT2 promoter with pro-
lactin, and we observed in both studies an increase in the SNAT2 expression or promoter activity. Consumption
of a high-protein/low carbohydrate diet increased prolactin concentration, with a concomitant increase in SNAT2
expression not only in the MG during lactation, but also in the liver and adipose tissue. There was a correlation
between SNAT2 expression and serumprolactin levels depending on the amount of dietary protein/carbohydrate
ratio consumed. These ﬁndings suggest that prolactin actively supports lactation providing amino acids to the
gland through SNAT2 for the synthesis of milk proteins.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Lactation is a physiological process necessary to provide all nutrients
to the newborns. This process is fundamental for all mammals, and it re-
quires large amounts of building block substrates for the synthesis of
proteins, triglycerides and lactose among others for the milk synthesis.
Thus, circulating amino acids from the mother are actively taken uplic adenosinemonophosphate;
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56553038.for protein synthesis. It has been evidenced that during the lactation pe-
riod the most abundant amino acids transported into the mammary
gland are alanine and glutamine [1] and are particularly important in
regulating the amino acid intracellular pool. Speciﬁcally, glutamine is
an efﬂux substrate for other amino acid transporters like the amino
acid heteroexchanger system L (LAT1), facilitating the uptake of
branched-chain amino acids, particularly leucine that activates the
TOR pathway involved in protein synthesis [2,3].
These amino acids, alanine and glutamine, as well as other small
neutral amino acids are mainly transported across membranes through
System Awhich is comprised by three subtypes known as SNATs (sodi-
um-coupled neutral amino acid transporters) 1, 2 and 4 [4]. However,
SNAT2, which represents the classical characteristics of System A, is
widely expressed in mammalian cells and is Na+-dependent [5–7].
Additionally, SNAT2 is regulated by environmental conditions, prolifer-
ative stimuli, developmental changes, and hormonal signals [8].
Several studies showed that themammary glands possess character-
istics of System A activity [9,10], determined by using the non-
metabolizable analog MeAIB. In addition, SNAT2 in the mammary
gland shows a unique characteristic of this transport system observed
in other cell types called adaptive regulation [11].
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gene expression in themammary gland. There is evidence during gesta-
tion of an increase in the SNAT2 mRNA abundance in this tissue that is
associated with concomitant changes in serum estradiol levels [12].
Recently, it has been demonstrated that upregulation of SNAT2 gene ex-
pression during gestation ismediated by the estrogen receptorα bound
to the coactivator glyceraldehyde 3-phosphate dehydrogenase that spe-
ciﬁcally binds to an estrogen response element found in the SNAT2 gene
promoter [13]. Interestingly, we have evidence that after gestation,
there is a second increase of SNAT2 mRNA that reaches its maximal in
the peak of lactation in the mammary gland [12]. There is preliminary
evidence that suggests that prolactin could be responsible for themain-
tenance and regulation of this amino acid transporter during lactation,
however this has not been established.
Prolactin is a single polypeptide with a molecular weight of 23 kDa
that is produced in the pituitary gland [14]. This hormone is secreted
with a pulsatile pattern during this physiological stage [15]. Prolactin
has two receptor isoforms, a long- and a short-isoform [16]. Interesting-
ly, the mammary gland during lactation mainly expresses the long-
isoform which activates several signaling pathways, particularly those
involving JAK2/STAT5, PI3K/PKBandMAPK [14]. It is known that prolac-
tin is involved in the activation of the expression of several genes that
include the β-casein gene to synthesize one of the most abundant pro-
teins in milk via the STAT5 transcription factor [17]. Therefore, in
order to sustain an elevated rate of milk protein synthesis, the supply
of large amounts of amino acids is necessary. There is evidence that
the expression of several amino acid transporters is up-regulated during
lactation, including SNAT2 [18–20].
Interestingly, It has been demonstrated that incubation ofmammary
gland explants with prolactin increases the uptake of amino acids
transported via System A [21]. However, there are no studies that
have established whether prolactin in fact increases the expression of
SNAT2 in the mammary gland.
Moreover, it has been demonstrated that the circulating levels of
prolactin are dependent on the amount of dietary protein consumed.
The lower the amount of protein, the lower the concentration of
serum prolactin [22]. As a result there is a decrease in milk production
that is reﬂected in the growth pattern of the pups. It is important to
study whether the changes in the dietary protein/carbohydrate ratio
may affect the expression of SNAT2 not only in the mammary gland
but also in other tissues such as the adipose tissue and liver. It has
been demonstrated that the prolactin receptor is present in these tis-
sues among others [23–27]. However, there is no knowledge whether
during lactation the SNAT2 gene is regulated in a similar fashion in
these tissues compared with the mammary gland.
Therefore, the aim of the present work was to demonstrate if there
are changes in SNAT2 protein abundance before delivery and during lac-
tation, to study if prolactin was able to increase the expression and pro-
moter activity of SNAT2 inmammary gland explants and T47D cells and
ﬁnally, to establish whether the dietary protein/carbohydrate ratio may
inﬂuence serum prolactin levels and SNAT2 gene expression in the
mammary gland, liver and adipose tissue.2. Materials and methods
The experimental design and procedures of this study were
reviewed and approved by the Animal Care Committee of the Instituto
Nacional de Ciencias Médicas y Nutrición, México, in accordance with
the international guidelines for the use of animals in research.2.1. Animals
This study was divided into two independent studies in order to
achieve the objectives described.2.1.1. Study 1
This studywas designed to determine the change in SNAT2 gene ex-
pression during late gestation and lactation. Female Wistar rats
weighing 200–250 g were obtained from the animal research facility
at the Instituto Nacional de Ciencias Médicas y Nutrición. The animals
were housed in individual stainless steel cages at 21 °C with a 12:12 h
light–dark cycle. The animals were allowed free access to water and
chow diet. Gestational age was determined by vaginal smear to detect
spermatozoa.Mammary gland explantswere obtained as previously re-
ported [11] from pregnant rats at day 20, lactating rats at days 5, 12, and
18, or weaning (rats 21 days postpartum separated from their pups for
24 h). After normal pregnancy and delivery, the litter size was adjusted
to 8 pups/dam. Five rats per group were used.
2.1.2. Study 2
This study was designed to determine if dietary protein modiﬁes
SNAT2 protein abundance during late gestation and lactation. The rat
strain, the maintenance thereof, and the gestational age determination
were the same as study 1. The animals were allowed free access to
water and to a low-protein/high-carbohydrate (10/73%), normal-
protein/normal-carbohydrate (20/63%) or high-protein/low-carbohy-
drate (30/53%) diets, according to the American Institute of Nutrition
(AIN93) lab rodent diet recommendations [28]. The adipose tissue,
liver and mammary gland were obtained from pregnant rats on day
20, or rats that had been lactating for 5 and 12 days. After delivery, the
litter size was adjusted to 8 pups/dam. Five rats per group were used.
The food intake of the dams was recorded daily, and the dams and
pups were weighed every other day.
2.2. Quantitative real-time PCR
Total RNA was extracted from the mammary gland by the
guanidinium thiocyanate–cesium chloride method as previously de-
scribed [12]. The RNA concentration was measured using a NanoDrop
spectrophotometer 1000 (ND-1000; Thermo Scientiﬁc, Wilmington,
De, USA). RNA integrity was corroborated by visualizing the 28S and
18S ribosomal subunits in a 1% (w/v) agarose gel and quality was
assessed with the 260/280 nm ratio absorbance of 2.0. RNA (3 μg) was
reverse-transcribed to cDNA by the use of Moloney murine leukemia
virus (MMLV) reverse transcriptase (Invitrogen). For the real-time PCR
analyses, 300 ng of cDNA was used in a ﬁnal reaction volume of 10 μl
per reaction. Predesigned TaqMan assay (Applied Biosystems, Foster
City, CA, USA) probes for sodium-coupled neutral amino acid transport-
er SNAT2 (Rn00710421_m1) andHPRT1 (hypoxanthinephosphoribosyl
transferase 1) (Rn01527840_m1) were used. RT-PCR was performed
using the following PCR ampliﬁcation conditions: denaturation for
5 min at 95 °C, annealing for 1 min at 56.2 °C, extension for 1.30 min
at 72 °C for 34 cycles; and ﬁnal extension for 7 min at 72 °C. The ampli-
ﬁcation and detection of speciﬁc products was performed with the ABI
PRISM 7000 (Applied Biosystems). The mRNA level of the SNAT2 was
normalized to the HPRT1 gene. HPRT1 was used as a housekeeping
gene since cyclophilin or β-actin showed great variation among sam-
ples. The relative amount of mRNA was calculated using the compara-
tive CT method (User Bulletin no. 2; PE Applied Biosystems).
2.3. Western blot
Proteinswere extracted from themammary gland, liver and adipose
tissue using RIPA (radio-immunoprecipitation assay) lysis buffer con-
taining the following: 50 mmol/l Tris–HCl, pH 7.4, 150 mmol/l NaCl,
1% NP40, 0.25% Na-deoxycholate, and 1 mmol/l PMSF. We added a 1×
Roche mini complete protease mixture. The protein concentration was
measured in duplicate using the Lowry method. Before being loaded,
the samples were prepared by mixing 40 μg of protein with Laemmli
buffer in a 1:1 ratio and heated at 80 °C for 5 min.
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gel (8% v/v), and transferred onto a polyvinylidene diﬂuoride (PVDF)
membrane (Amersham GE Healthcare). For gel electrophoresis and
semi-dry transfer, we used a Tris/glycine buffer. After transfer, the
membranes were blockedwith 5% (w/v) non-fat milk blocking solution
with 1× Tris-buffered saline (TBS) and 0.1% Tween 20 for 1 h. Themem-
branes were incubated overnight at 4 °C with the different primary an-
tibodies as follows: SNAT2 (Santa Cruz Biotechnology, sc-166366,
1:800), and β-actin (Santa Cruz Biotechnology, sc-1615, 1:1000),
which were diluted in TBS, 5% (w/v) non-fat milk and 0.1% Tween 20.
We used different secondary HRP (horseradish peroxidase) conjugated
antibodies as follows: anti-mouse IgG-HRP (Santa Cruz Biotechnology,
sc-2005, 1:3500) and anti-goat IgG-HRP (Santa Cruz Biotechnology,
sc-2768, 1:3500) diluted in TBS, 5% (w/v) non-fat milk and 0.1%
Tween 20. The chemiluminescence produced was measured using the
Amersham Enhanced Chemiluminescence (ECL) detection reagents by
exposure to X-ray ﬁlm.
2.4. Immunohistochemistry
For the immunohistochemistry examination, rat mammary gland
was obtained from pregnant rats at day 20, or lactating rats at 5 and
12 days. Before staining, tissue sections were immersed in 10% (v/v)
hydrogen peroxide (H2O2)/methanol for 15 min, washed in two
changes of distilled water (2 × 5 min) and deparafﬁnized through
xylene and different percentages of ethanol (100, 95, and 70%
twice). Sections were rinsed in phosphate-buffered saline (PBS),
pH 7.4, and blocked for 30 min in 3% (v/v) bovine serum albumin
(BSA) in PBS. The primary antibody used was mouse polyclonal
afﬁnity-puriﬁed IgG anti-SNAT2 or 0.1 MPBS instead of primary anti-
bodies for negative controls. Primary antibodies were incubated
overnight for 18 h at 4 °C. Conventional immunohistochemistry
was performed using a biotinylated goat anti-mouse secondary anti-
body. After extensive wash using PBS, the color reaction was devel-
oped with diaminobenzidine (DAB; Sigma-Aldrich) in PBS and 30%
(v/v) H2O2 for about 10 min. Slides were washed with deionized
water, air-dried, and counterstained.
2.5. Preparation of mammary tissue explants
Mammary tissue explants were prepared as described previously
[11]. Brieﬂy, rats were anesthetized and themammary glandwas im-
mediately removed and placed at 37 °C in 30 ml of Krebs–Ringer bi-
carbonate buffer, pH 7.4, equilibrated with 95% O2–5% CO2 and
contained the following (in mmol/l): 141 NaCl, 5.6 KCl, 3.0 CaCl2,
1.4 KH2PO4, 1.4 MgSO4, 24.6 NaHCO3, and 11 glucose. After the re-
moval of the connective tissue, the mammary tissue was diced into
2- to 5-mg explants. The tissue explants were rinsed repeatedly
with buffer at 37 °C prior to assay. The explants were incubated in
the presence of 0, 25, 250 or 2500 ng/ml of prolactin for 1 h. Subse-
quently, the mammary tissue was used to determine the SNAT2
gene expression by quantitative real-time PCR and western blot
techniques as mentioned above.
2.6. Transfection and reporter gene assays
Human T47D mammary gland ductal carcinoma cells that express
the prolactin receptor were grown in RPMI (Roswell Park Memorial In-
stitute)medium supplementedwith 5% fetal bovine serum, L-glutamine
(2mM), penicillin (100U/ml), and streptomycin (100 μg/ml) at 37 °C in
a 5% CO2 incubator. The p-SNAT2 promoter (−1872 to +265 bp) con-
struct was inserted in the pGL3 basic vector (Promega, Fitchburg, WI,
USA), which contained a luciferase reporter gene. T47D cells (150,000
cells/well) were plated in 12-well plates in RPMImedium, supplement-
ed with 5% fetal bovine serum (FBS) 24 h before transfection. Transient
transfection on Human T47D cells was performedwith 0.25 μg of the p-SNAT2 luciferase reporter gene construct and 0.01 μg of pRL-TK Renilla
expression vector (Promega, Fitchburg, WI, USA), used as an internal
control to normalize the transfection efﬁciency, using the PolyFect
(Qiagen) reagent according to the manufacturer's instructions. After
transfection, the cells were incubated with different concentrations of
prolactin (2, 20, 200, 2000 or 20,000 ng/ml) or without prolactin
referred as control. Luciferase activity was measured as relative light
units with a Veritas microplate luminometer (Turner Biosystems,
Sunnyvale, CA). Each transfection was performed in triplicate, and
three independent experiments were performed for each construct.
2.7. Serum prolactin quantiﬁcation
Prolactin determinationswere done in duplicate by speciﬁc radioim-
munoassay (RIA) using reagents and protocols provided by the National
Hormone and Peptide Program (Torrance, CA 90509, USA). The results
are expressed in terms of the international reference standard NIDDK-
rPRL-RP-3. The coefﬁcients of variation intra- and interassay were 8.7
and 14.1, respectively. All samples were analyzed together to eliminate
interassay variability.
2.8. Statistical analysis
The results are reported as the means ± SEM and gene expression
data were tested using a 1-way and 2-way ANOVA, and signiﬁcant dif-
ferences among groups were analyzed by Bonferroni adjustments. The
linear regression method was used to analyze correlations. Differences
were considered signiﬁcant at P b 0.05.
3. Results
3.1. Protein expression of SNAT2 in the mammary gland during gestation
and lactation
Thewestern blot analysis revealed that SNAT2 protein abundance in
the mammary gland increased during lactation. From delivery until day
5 of lactation, there was an increase of about 11.7-fold, and this was
maintained until the peak of lactation (days 12 and 18). After 24-h
weaning SNAT2 protein tended to decrease however it did not reach sta-
tistical signiﬁcance (Fig. 1A, B). To determine the cellular localization of
SNAT2, immunohistochemistry was performed in the mammary gland
from pregnant, lactating and weaning rats. The mammary gland from
rats after delivery showed a poor SNAT2 immunostaining (Fig. 1C). In
contrast, at days 5 and 12 of lactation (Fig. 1D, E respectively) a strong
SNAT2 immunostainingwas seen in alveolar cells, while duringweaning
a decrease of immunoreactivity was observed (Fig. 1F). These results
well correlated with the expression of SNAT2 protein studied with
western blot (Fig. 1A, B).
3.2. Effect of prolactin on the expression of SNAT2
Prolactin stimulated SNAT2 mRNA and protein abundance in mam-
mary gland explants. Incubation of explantswith 25ng/ml for 6 h signif-
icantly stimulated SNAT2 concentration by approximately 24%, and
with 250 ng/ml the increment in the protein abundance was about
49%. Further increase in the concentration of prolactin did not have an
additional stimulation in the SNAT2 protein concentration (Fig. 2A).
We then performed a time course analysis to assess the effect of pro-
lactin on the expression of SNAT2 in mammary gland explants. For this
study we added 250 ng/ml of prolactin to the explants. Our data clearly
showed that prolactinwas able to signiﬁcantly stimulate SNAT2 expres-
sion in mammary gland explants, and this response initiated at about
6 h of incubation reaching themaximal response after 8 h of incubation
by approximately 4.5-fold. Then, after 10 h of incubation we observed a
sharp decrease in the expression of this transporter (Fig. 2B).
Fig. 1. SNAT2 protein abundance in rat mammary gland. A) A representative immunoblot of SNAT2 and actin as constitutive protein of gestation day 20; lactation days 5, 12, and 18; and
weaning. B)Western blot densitometric analysis of SNAT2/actin. Values are themean± SEM of three different blots. n= 5. Representative immunohistochemistry of SNAT2 detection in
different physiological phases of the mammary gland. C) Day 20 of gestation shows almost negative SNAT2 detection D) at day 5 and E) day 12 of lactation there is a strong SNAT2 im-
munostaining in lobular epithelial cells. F) During weaning there is a mild SNAT2 immunostaining (all micrograph scale bars: 50 μm).
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SNAT2 promoter region showed a signiﬁcant increase in the luciferase
activity after incubatingwith 20, 200, 2000 and 20,000 ng/ml compared
to the control without prolactin stimulus. The maximum effect was ob-
served with 200 ng/ml concentration having a two-fold increase in the
SNAT2 promoter activity (Fig. 2C). These results demonstrate that pro-
lactin is able to activate SNAT2 transcription in vitro.3.3. Effect of the dietary protein/carbohydrate ratio in the diet on the
expression of SNAT2
To determine whether the supply of the amino acid/carbohydrate
ratio, provided by the consumption of different amounts of dietary pro-
tein, could modify SNAT2 expression after delivery and during lactation
in different tissues (mammary gland, liver and white adipose tissue),
we measured the expression of the SNAT2 protein abundance in these
tissues from rats fed with a low-protein/high-carbohydrate (10/73%),
or a normal-protein/normal-carbohydrate (20/63%) or a high-protein/
low-carbohydrate (30/53%) diet. We observed that SNAT2 was
expressed in the mammary gland, as well as in the white adipose tissue
and liver as has been previously reported [29]. In the mammary gland
we found the same SNAT2 protein abundance just before delivery inde-
pendently of the amount of dietary protein/carbohydrate ratio
consumed. Interestingly, during the lactation period SNAT2 protein
abundance increased as the dietary protein/carbohydrate ratio in-
creased, particularly on days 5 and 12 of lactation (Fig. 3A).
In the liver and adipose tissue we observed a different expression
pattern depending on the dietary protein/carbohydrate ratio before de-
livery. Rats fed with a high-protein/low-carbohydrate (30/53%) diet
showed a signiﬁcant increase in the SNAT2 protein abundance, in con-
trastwith the results observed in themammary gland. However, during
lactation, SNAT2 protein expression followed a similar trend than the
observed in the mammary gland with a signiﬁcant increase of the
SNAT2 protein depending on the dietary protein/carbohydrate ratio
(Fig. 3B, C).3.4. Prolactin concentration during lactation increased as the dietary
protein/carbohydrate ratio increased and correlatedwith SNAT2 expression
To determinewhether the increase in SNAT2 expressionwas associ-
atedwith an increase in prolactin concentration as a consequence of the
dietary protein/carbohydrate ratio, we measured serum prolactin con-
centration during lactation.We observed that serum prolactin levels in-
creased as dietary protein/carbohydrate ratio increased during lactation
(Fig. 3D). Interestingly, we found a signiﬁcant correlation between
SNAT2 protein concentration and serum prolactin levels (r2 = 0.9854,
0.8935 and 0.9177 in the mammary gland, adipose tissue and liver re-
spectively) on day 12 of lactation (Fig. 4A–C).4. Discussion
Amino acids are essential nutrients for protein synthesis and other
metabolic functions. Particularly, during the lactation period there is a
sharp increase in the amino acid requirements to support the milk pro-
tein synthesis in themammary gland. Amino acids are captured into the
cells by amino acid transporters, which play an important role in this
physiological period to supply the amount of amino acids required. In
our study we showed that the expression of SNAT2, one of the most
abundant amino acid transporters, was regulated in the mammary
gland byprolactin stimuli aswell as by the dietary protein/carbohydrate
ratio during lactation.
We observed an increase of the SNAT2 protein abundance in the
mammary gland on day 5 of lactation. It is known that prolactin rapidly
rises in the ﬁrst days of lactation aswe also demonstrated bymeasuring
the serum levels of this hormone; therefore prolactin could contribute
to the up-regulation of SNAT2 protein abundance. In fact, we also
showed that prolactin can regulate the expression of this transporter
in mammary gland explants by incubating the tissue in the presence
of physiological levels reached by this hormone during the lactation pe-
riod. It is important to discuss that in this study,we decided to usemam-
mary gland explants from lactating rats because they are mainly
Fig. 2. Effect of prolactin in SNAT2 expression in rat mammary gland and T47D cells. A) A representative immunoblot of SNAT2 and actin, as constitutive protein, of mammary gland ex-
plants at day 12 of lactation incubatedwith 25, 250 and 2500 ng/ml of prolactin andwestern blot densitometric analysis of SNAT2/actin of mammary gland explant lactation day 12 in the
presence of different concentrations of prolactin. B) Time course (0, 2, 4, 6, 8, 10, 12h) of SNAT2 relativemRNA levels in ratmammary gland explants incubatedwith 250ng/ml of prolactin.
Values are the mean ± SEM of three different blots. n = 5. C) Effect of prolactin (PRL) on SNAT2 promoter activity in T47D mammary ductal carcinoma cells co-transfected with SNAT2
promoter–reporter construct and pRL-TK (Renilla expression vector for normalization), and incubated in the presence of different concentrations (2, 20, 200, 2000 or 20,000 ng/ml) of PRL
or without stimulus (control). The results are the mean ± SEM of 3 independent experiments. Different letters differ: a N b N c N d. P b 0.05.
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glands which have a considerable amount of adipose tissue. However,
the effect of exogenous prolactin in this experiment could be
misinterpreted byusing already lactatingdams that have been stimulat-
ed in vivo by the endogenous increase of this hormone. To clarify the ef-
fect of prolactin in SNAT2 expression we performed additional in vitro
studies in T47D cells using the promoter region of this gene, and incu-
bating the cells in the presence or absence of prolactin. Our results dem-
onstrated that physiological levels during lactation of this hormone
were able to signiﬁcantly increase SNAT2 promoter activity in T47D
cell line.
Viña and colleagues reported arteriovenous changes of amino acids
across the mammary gland, and that prolactin can regulate the amino
acid uptake by this tissue. Interestingly they observed a decrease in
the uptake of the SNAT2 substrates, specially alanine and glutamine
by adding the prolactin inhibitor bromocriptine [1]. Our data as well
as those observed by other authors suggest that the activity of SNAT2could be stimulated by prolactin during the ﬁrst days of lactation in
the mammary gland.
Interestingly, the SNAT2 protein abundance in the mammary gland
on day 12 of lactation, which corresponds to the maximal peak of milk
production in the rat, was dependent on the dietary protein/carbohy-
drate ratio consumed. It has been explored whether the amount of die-
tary protein could affect the levels of circulating prolactin.Moretto et al.
clearly demonstrated that in fact when rats consumed a low protein
diet, the concentration of serum prolactin was signiﬁcantly reduced
[22]. Our results also demonstrated that the dietary protein/carbohy-
drate ratio inﬂuences the serum prolactin concentration. This may
imply that the reduction of prolactin decreases SNAT2 expression or
that the dietary protein/carbohydrate ratio can directly modulate the
expression of this gene possibly via cAMP, as has been reported in the
liver [30]. Further studies are needed to dissect this mechanism.
Interestingly, the mechanisms involved in the regulation of SNAT2
expression in the mammary gland during gestation and lactation are
Fig. 3.Effect of dietary protein/carbohydrate ratio in SNAT2protein abundance and serumprolactin levels. A representative immunoblot andwestern blot densitometric analysis of SNAT2/
Actin in rat A) mammary gland, B) adipose tissue and C) liver; and D) prolactin serum levels during gestation day 20 and lactation days 5 and 12 of rats fed a low-protein/high-carbohy-
drate (10/73%), normal-protein/normal-carbohydrate (20/63%), or high-protein/low-carbohydrate (30/53%) diet. Values are the mean ± SEM of three different blots. n = 5. *P b 0.05,
**P b 0.01, ***P b 0.001. Different letters differ: a N b N c N d. P b 0.05.
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of expression in the liver and adipose tissue with respect to the mam-
mary gland during the last day of gestation. Before delivery, the expres-
sion of this transporter was not modiﬁed in the mammary gland due to
the dietary protein/carbohydrate ratio consumed,whereas during lacta-
tion there was an increase in SNAT2 expression that was dependent on
this ratio. It is known, that during lactation rats increase their food in-
take by 300% [31,32]. Therefore, the supply of amino acids is signiﬁcant-
ly increased when rats consumed a high protein diet as has been
previously reported [33]. It has been demonstrated that an increase in
the amount of dietary protein, stimulates the serum glucagon levels,
which in turn upregulates the expression of SNAT2 via PKA in the
liver, since the SNAT2 promoter gene contains a cAMP response ele-
ment (CRE) at−48 bp [30].
On the other hand, serum prolactin levels, modulated by the dietary
protein/carbohydrate ratio, can directly regulate the expression of this
transporter by activating its classical pathwaymediated by the prolactin
receptor not only in the mammary gland but also in other tissues such
as the liver and adipose tissue. The long form of the prolactin receptor
is expressed in the liver and adipose tissue [34,35], and prolactin plays
important roles in these organs during lactation. Moreno-Carranza
and colleagues demonstrated that prolactin promotes hepatic cellproliferation and survival, especially in neonates and lactating female
rodents [36]. In these stages, SNAT2 amino acid transporter regulated
by this hormone could be involved in this process. In the adipose tissue
it is known that prolactin receptor is increased during lactation and dif-
ferentiation, and that prolactin favors the adipogenesis process [37].
During the lactation period prolactin decreases lipogenesis and glucose
uptake in the adipose tissue favoring the contribution of energy sub-
strates to the mammary gland [38]. Further studies are needed to iden-
tify possible prolactin response elements in the SNAT2 gene to elucidate
the molecular mechanism by which this hormone regulates its expres-
sion during lactation. In silico analysis revealed that the SNAT2promoter
contains a putative STAT3 response element that could be involved in
the induction of this gene. We are conducting studies to understand
the possible molecular mechanism by which prolactin stimulates the
transcription of SNAT2 and its implication in several tissues during the
lactation period.
5. Conclusion
The mammary gland during the lactation period requires an active
uptake of amino acids to support the newborn needs. Our results sug-
gest that prolactin actively supports lactation by providing amino
Fig. 4. Correlation between SNAT2 protein abundance and serum prolactin levels. Linear regression of rat A) mammary gland, B) adipose tissue and C) liver SNAT2 protein concentration
and serum prolactin levels during lactation day 12 in rats fed a low-protein/high-carbohydrate (10/73%), normal-protein/normal-carbohydrate (20/63%), or high-protein/low-carbohydrate
(30/53%) diet.
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pression of amino acid transporters, particularly SNAT2, for the synthe-
sis of milk proteins. The dietary protein/carbohydrate ratio consumed
also inﬂuenced SNAT2 abundance and correlated with serum prolactin
levels not only in the mammary gland, but also in the liver and adipose
tissue indicating a newway of regulation of this amino acid transporter
expression.
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